Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southwest Pharmaceutical, a subsidiary of Taiji Group and part of the Sinopharm network, is a prominent pharmaceutical manufacturer based in Chongqing, China. Established in 1950, the company has evolved into a large-scale production base for chemical drugs, specializing in finished dosage forms including tablets, capsules, and injections. Its product portfolio covers a wide range of therapeutic areas such as anti-infectives, cardiovascular health, and central nervous system disorders. The company is recognized for its high-volume manufacturing capabilities and its role in producing essential medicines for the Chinese healthcare system. Southwest Pharmaceutical operates multiple GMP-certified facilities and maintains a significant presence in both domestic and international generic drug markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Southwest Pharmaceutical.